Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice
- PMID: 2230116
Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice
Abstract
IL-1 is a multifunctional, immunoregulatory polypeptide produced by many cell types. Because activated macrophages are a major source of IL-1 and have also been implicated in the pathogenesis of autoimmune disease, we investigated the regulation of IL-1 expression in several autoimmune-prone strains of mice. Peritoneal macrophages derived from the autoimmune-prone strains MRL/lpr, MRL/+, NZB, and NZB/W F1, as well as NZW, displayed transient expression of IL-1 in contrast to the stable expression characteristic of control normal strains including A. Thy, A/J, B10, B10.A, B10.D2, C57BL/6, BALB/c, and C3H/HeN. The down-regulation of IL-1 by macrophages from the autoimmune-prone mice was not attributable to inherently defective signal transduction because macrophages from both the normal and autoimmune-prone strains displayed substantial initial levels of cell-associated and secreted IL-1. However, during the first 2 to 3 days in culture, macrophages from autoimmune-prone mice became progressively refractory to both induction and maintenance of IL-1, a pattern that correlated with changes in the levels of IL-1 alpha and beta mRNA. The progressive reduction in IL-1 expression by macrophages from these autoimmune-prone strains was not due to a reduction in general metabolism or viability, because expression of cell surface antigens, including MHC class I and II Ag and LFA-1, was comparable to that of control macrophages. Because IL-1 plays a critical role in the homeostasis of a variety of cell lineages, defective expression, and maintenance of IL-1 (and perhaps other cytokines) by macrophages from the autoimmune-prone strains may contribute to the immune dysregulation that develops in these mice. Alternatively, cytokine dysregulation might not contribute directly to disease, but rather reflect a more basic defect related to specific signal transducing or gene regulatory pathways.
Similar articles
-
Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice.J Immunol. 1997 Dec 1;159(11):5610-9. J Immunol. 1997. PMID: 9548504
-
Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.J Immunol. 1998 Dec 15;161(12):6878-84. J Immunol. 1998. PMID: 9862720
-
Adhesion elicits an intrinsic defect in interleukin-1 expression by macrophages from autoimmune-prone MRL mice.J Autoimmun. 1998 Apr;11(2):141-50. doi: 10.1006/jaut.1997.0182. J Autoimmun. 1998. PMID: 9650093
-
Interleukin-6 in autoimmune disorders.Semin Immunol. 1992 Jun;4(3):155-66. Semin Immunol. 1992. PMID: 1627787 Review.
-
Cytokine dysregulation and the initiation of systemic autoimmunity.Immunol Lett. 1994 Dec;43(1-2):15-21. doi: 10.1016/0165-2478(94)00144-8. Immunol Lett. 1994. PMID: 7737685 Review.
Cited by
-
The super super-healing MRL mouse strain.Front Biol (Beijing). 2012 Dec 1;7(6):522-538. doi: 10.1007/s11515-012-1192-4. Front Biol (Beijing). 2012. PMID: 24163690 Free PMC article.
-
Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus.Ann Rheum Dis. 1993 May;52(5):378-83. doi: 10.1136/ard.52.5.378. Ann Rheum Dis. 1993. PMID: 8323386 Free PMC article. Review.
-
Macrophages from lupus-prone MRL mice have a conditional signaling abnormality that leads to dysregulated expression of numerous genes.Immunogenetics. 2011 May;63(5):291-308. doi: 10.1007/s00251-010-0507-3. Epub 2011 Jan 13. Immunogenetics. 2011. PMID: 21229240 Free PMC article.
-
Macrophages are necessary for epimorphic regeneration in African spiny mice.Elife. 2017 May 16;6:e24623. doi: 10.7554/eLife.24623. Elife. 2017. PMID: 28508748 Free PMC article.
-
The dysregulation of cytokine networks in systemic lupus erythematosus.J Interferon Cytokine Res. 2011 Oct;31(10):769-79. doi: 10.1089/jir.2011.0029. Epub 2011 Aug 30. J Interferon Cytokine Res. 2011. PMID: 21877904 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials